Today's Daily Dose brings you news about Invitae's secondary offering; BIOLASE's fourth-quarter financial results; Celgene's regulatory catalyst in September; and Endologix's reverse stock split, and the resignation of Scott Gottlieb as FDA Commissioner.
from RTT - Biotech https://ift.tt/2EE4pD4
via IFTTT
No comments:
Post a Comment